SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS AND THE POTENTIAL FOR DIABETIC KETOACIDOSIS

被引:0
|
作者
Melnick, Stephen [1 ]
Basnet, Sijan [2 ]
Sharma, Priyadarshani [3 ]
Nazir, Salik [4 ]
机构
[1] Reading Hlth Syst, Lebanon, PA USA
[2] Reading Hosp, W Reading, PA USA
[3] Reading Hosp, Reading, PA USA
[4] Reading Hlth Syst, W Reading, PA USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:S617 / S618
页数:2
相关论文
共 50 条
  • [41] Sodium-glucose co-transporter-2 inhibitors and the risk of perioperative euglycaemic diabetic ketoacidosis
    Williams, Samuel P.
    Stevens, Jia L.
    Rajendran, Yohinee K.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2022, 83 (11)
  • [42] Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
    Chan, Anthony T. P.
    Tang, Sydney C. W.
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (06) : 682 - 698
  • [43] Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy?
    Neumiller, Joshua J.
    Rhee, Connie M.
    Kalantar-Zadeh, Kamyar
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (06) : 459 - 461
  • [44] Sodium Glucose Co-transporter Inhibitors in Patients with Acromegaly and Diabetes
    Adnan, Zaina
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (02): : 77 - 79
  • [45] Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
    Thomson, Scott C.
    Vallon, Volker
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10): : S30 - +
  • [46] Impact of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiac Protection
    Wu, Victor Chien-Chia
    Li, Yan-Rong
    Wang, Chao-Yung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [47] Sodium-glucose co-transporter 2 inhibitors: evidence and place in therapy
    Minze, Molly G.
    Koffarnus, Robin L.
    Bailey, Trista A.
    Diec, Sandy
    Edwards, Krystal L.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 645 - 661
  • [48] Are sodium-glucose co-transporter 2 inhibitors safe in hypertrophic cardiomyopathy?
    Biletska, V.
    Tseluyko, V.
    Kinoshenko, K.
    Butko, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 510 - 510
  • [49] Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
    Bo Liang
    Ning Gu
    Cardiovascular Diabetology, 21
  • [50] Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
    Thomson, Scott C.
    Vallon, Volker
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 : S28 - S35